摘要
目的:探讨焦虑障碍伴发2型糖尿病采用艾司西酞普兰联合团体心理治疗的临床疗效。方法:选取我院2016-02～2018-02收治的66例焦虑障碍伴发2型糖尿病病人进行研究,随机分为两组,对照组进行单一草酸艾司西酞普兰治疗,观察组在此基础上使用团体心理治疗,对比其临床疗效。结果:治疗半年后,两组病人的空腹血糖(FPG)无差异性(P>0.05),观察组病人的餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA 1 c)以及HAMA评分显著优于对照组,存在明显差异性,有统计学意义(P<0.05)。结论:焦虑障碍伴发2型糖尿病采用艾司西酞普兰联合团体心理治疗可以改善病人的血糖水平,缓解其心理情绪,其疗效优于单一使用药物治疗。
Objective： To explore the clinical efficacy of the combination of escitalopram combined with group psychotherapy in type 2 diabetes with anxiety disorder. Methods： 66 patients with anxiety disorders admitted to our hospital from February 2016 to February 2018 were selected and randomly divided into two groups. The control group was treated with single Ai Sciplan treatment. The observation group was treated with group psychotherapy and the clinical efficacy was compared. Results： After six months′ treatment, there was no difference in FPG between the two groups （ P 〉 0.05 ）. The 2 hPG, HbA 1 c and HAMA scores in the observation group were significantly better than those in the control group, with significant difference （ P 〈 0.05 ）. Conclusion： The combination of escitalopram combined with group psychotherapy in type 2 diabetes with anxiety disorder can improve the blood glucose level and relieve the mental mood of the patients.
作者
白延欣
方袁
BAI Yan-xin;FANG Yuan(Inner Mongolia Mental Health Care,Hohhot 010010 China)
出处
《内蒙古医科大学学报》
2019年第1期56-58,共3页
Journal of Inner Mongolia Medical University
关键词
艾司西酞普兰
团体心理
焦虑障碍
2型糖尿病
疗效
ai sciplan
group psychology
anxiety disorder
type 2 diabetes
curative effect
